FATE
Fate Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
FATE fundamentals
Fate Therapeutics (FATE) released its earnings on Aug 12, 2025: revenue was 1.91M (YoY -71.80%), beat estimates; EPS was -0.29 (YoY +12.12%), beat estimates.
Revenue / YoY
1.91M
-71.80%
EPS / YoY
-0.29
+12.12%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 12, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
FATE has released its 2025 Q3 earnings report, with revenue of 1.74M, reflecting a YoY change of -43.36%, and net profit of -32.25M, showing a YoY change of 32.36%. The Sankey diagram below clearly presents FATE's revenue sources and cost distribution.
Key Indicators
Fate Therapeutics (FATE) key financial stats and ratios, covering profitability, financial health, and leverage.
Fate Therapeutics (FATE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Fate Therapeutics (FATE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Fate Therapeutics (FATE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Fate Therapeutics (FATE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Fate Therapeutics (FATE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Fate Therapeutics next quarter?What does Fate Therapeutics do and what are its main business segments?What were the key takeaways from Fate Therapeutics’s earnings call?What is Fate Therapeutics's gross profit margin?Did Fate Therapeutics beat or miss consensus estimates last quarter?What is Fate Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Fate Therapeutics's earnings call?What guidance did Fate Therapeutics's management provide for the next earnings period?
